InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Galvin Roy. Officer active across 2 companies, notably HAEMONETICS CORP. Cumulatively, 10 disclosures have been recorded. Activity tracked since 1 November 2023. The latest transaction was disclosed on 31 October 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Galvin Roy is EVP, Chief Commercial Officer at HAEMONETICS CORP and Haemonetics CORP. He has 10 filings in total, and the sampled recent filings run from 2022-11-03 to 2025-11-03, with transactions of nature Tax withholding; sum_buy_eur and sum_sell_eur are both 0.